← Back to all trials
Recruiting
NCT06397469
Enhancing Attention and Wellbeing Using Digital Therapeutics
Conditions: Aging, MCI, Cognitive Decline
Sex: All
Ages: 60 Years – 99 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 4000
Sponsor: University of California, San Francisco
Location: University of California San Francisco San Francisco California
Summary
The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity). This knowledge gained from his high-impact study with transform the field of cognitive interventions, paving the way for a precision medicine model for cognitive enhancing interventions that improve quality of life for older adults and individuals with cognitive deficits at risk of developing dementia.
Eligibility Criteria
Inclusion Criteria:
* 60+ years old (adult)
* English language fluency
* owning a smartphone or tablet
Exclusion Criteria:
* Under 60 years old (minor)
Source: ClinicalTrials.gov (NCT06397469). StuddyBuddy aggregates publicly available trial information.